Sven H. Almer

机构：Karolinska University Hospital, Karolinska Institutet, Karolinska Development (Sweden) · ORCID：0000-0001-9334-1821

发表论文 298 篇 · 总被引 18453 次 · h-index 57

代表论文

• Tissue-specific transcriptional imprinting and heterogeneity in human innate lymphoid cells revealed by full-length single-cell RNA-sequencing (2021 · Cell Research · 被引 175)
• Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial (2023 · ˜The œLancet. Gastroenterology & hepatology · 被引 113)
• Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3−ILC1/NK cell transdifferentiation (2019 · European Journal of Immunology · 被引 98)
• Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study (2021 · ˜The œLancet. Gastroenterology & hepatology · 被引 96)
• Discontinuation of Infliximab Therapy in Patients with Crohn’s Disease (2022 · NEJM Evidence · 被引 54)
• Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis (2020 · Clinical Gastroenterology and Hepatology · 被引 51)